Showing results (181-190 of 3,904) with videos related to
Sort By:
Pageof 391
American Journal of Cancer Research|January 30, 2013
Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophagesDerick Okwan-Duodu, Guillermo E Umpierrez, Otis W Brawley, et al.American Journal of Cancer Research|January 30, 2013
Life after death: targeting high mobility group box 1 in emergent cancer therapiesZ Sheng Guo, Zuqiang Liu, David L Bartlett, et al.American Journal of Cancer Research|January 30, 2013
Role of heparan sulfatases in ovarian and breast cancerAshwani Khurana, Daniah Beleford, Xiaoping He, et al.American Journal of Cancer Research|January 30, 2013
LXR, prostate cancer and cholesterol: the Good, the Bad and the UglyHugues de Boussac, Aurélien Jc Pommier, Julie Dufour, et al.American Journal of Cancer Research|January 30, 2013
Morphologic and other clinicopathologic features of endometrial clear cell carcinoma: a comprehensive analysis of 50 rigorously classified casesOluwole Fadare, Wenxin Zheng, Marta A Crispens, et al.American Journal of Cancer Research|December 11, 2012
Non-coding RNAs in DNA damage responseYunhua Liu, Xiongbin LuAmerican Journal of Cancer Research|November 10, 2017
Elucidating immunometabolic targets in glioblastomaPooja Agarwal, Michael J Pajor, David M Anson, et al.American Journal of Cancer Research|November 10, 2017
USP51 promotes deubiquitination and stabilization of ZEB1Zhicheng Zhou, Peijing Zhang, Xiaoyu Hu, et al.American Journal of Cancer Research|November 10, 2017
Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesisTakashi Kawahara, Satoshi Inoue, Eiji Kashiwagi, et al.American Journal of Cancer Research|October 6, 2017
Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies GRIA1 as a prognostic biomarker for basal-like bladder cancerSloane K Tilley, William Y Kim, Rebecca C FryPageof 391